Skip to main content
FATE logo

FATE

Fate Therapeutics Inc
$2.99 -0.03 (-0.99%) At close · Jul 14
Market Cap
$348.51M
Shares
116,559,186

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 157
Total Value: $84,420,819
Total Shares: 70,097,665
Showing 1–100 of 162 holdings by value · page 1 of 2

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 156 13F filers
Top Holder
18.4%
Jun 2023 → Mar 2026 · range 10.7% – 18.4%
of institutional value
Top 5
49.5%
Jun 2023 → Mar 2026 · range 39.0% – 54.8%
of institutional value
Top 10
69.8%
Jun 2023 → Mar 2026 · range 55.4% – 70.0%
of institutional value
HHI
753
Jun 2023 → Mar 2026 · range 430 – 789
Broadly held
Showing 100 of 162
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1434316 CUSIP 31189P102 13F (30d) 7 filings 7 filers Visit website Investor relations